EconPapers    
Economics at your fingertips  
 

Prevention of pancreatic acinar cell carcinoma by Roux-en-Y Gastric Bypass Surgery

Rui He, Yue Yin, Wenzhen Yin, Yin Li, Jing Zhao and Weizhen Zhang ()
Additional contact information
Rui He: and Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Peking University Health Science Center
Yue Yin: and Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Peking University Health Science Center
Wenzhen Yin: and Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Peking University Health Science Center
Yin Li: and Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Peking University Health Science Center
Jing Zhao: and Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Peking University Health Science Center
Weizhen Zhang: and Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Peking University Health Science Center

Nature Communications, 2018, vol. 9, issue 1, 1-7

Abstract: Abstract Roux-en-Y Gastric Bypass Surgery (RYGB) prevents the occurrence of pancreatic cell acinar carcinoma (ACC) in male and female Ngn3-Tsc1−/− mice. Ngn3 directed Cre deletion of Tsc1 gene induced the development of pancreatic ACC. The transgenic mice with sham surgery demonstrated a cancer incidence of 96.7 ± 3.35% and survival rate of 67.0 ± 1.4% at the age of 300 days. Metastasis to liver and kidney was observed in 69.7 ± 9.7% and 44.3 ± 8.01% of these animals, respectively. All animals with RYGB performed at the age of 16 weeks survived free of pancreatic ACC up to the age of 300 days. RYGB significantly attenuated the activation of mTORC1 signaling and inhibition of tumor suppressor genes: p21, p27, and p53 in pancreatic ACC. Our studies demonstrate that bariatric surgery may limit the occurrence and growth of pancreatic ACC through the suppression of mTORC1 signaling in pancreas. RYGB shows promise for intervention of both metabolic dysfunction and organ cancer.

Date: 2018
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41467-018-06571-w Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-06571-w

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-018-06571-w

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-03-19
Handle: RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-06571-w